Conclusion: High body mass index is associated with high
bone mineral density and reduced fracture risk in postmenopausal females.
We hypothesized that an increase in muscle strength and preservation of
bone mineral density in elderly women occurs with 10 wks of resistance training of moderate intensity.
Previous trials have shown that denosumab increased
bone mineral density in women previously treated with oral bisphosphonates, whereas zoledronic acid did not, in women previously treated with alendronate.
No one had an active or ongoing inflammatory condition (except HIV infection), and no one had an earlier fracture suggesting low
bone mineral density or an earlier heart attack.
The results of this study were showed a significant correlation between
bone mineral density and age (r = -0.
Previous data have shown that severe renal dysfunction is associated with reduced
bone mineral density and fractures, and that a creatinine clearance below 65 mL/min per 1.
At the six month time point, there is no evidence that Androxal reduces
bone mineral density as assessed by DEXA scans.
Bone mineral density of lumbar spine and total body were assessed at baseline and at three months using dual-energy X-ray absorptiometry.
The method involves combining
bone mineral density measures with body size and bone size to create composite bone strength indices.
In the study, researchers reviewed guidelines for calcium and/or vitamin D supplementation, the results of 12 clinical trials of supplemental calcium and/ or vitamin D in men with prostate cancer undergoing ADT, and the measurements of
bone mineral density before and after ADT.
Bone mineral density of women was evaluated by Dual Energy X-ray Absorptiometrey (DEXA) and its association was analyzed with urinary calcium creatinine ratio and urinary phosphate creatinine ratio.
Women who have their ovaries removed have lower
bone mineral density than women with ovaries.
